
Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
Verhagen, Caroline V.M., de Haan, Rosemarie, Hageman, Floor, Oostendorp, Tim P.D., Carli, Annalisa L.E., O’Connor, Mark J., Jonkers, Jos, Verheij, Marcel, van den Brekel, Michiel W., Vens, ConchitaLangue:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/j.radonc.2015.03.028
Date:
May, 2015
Fichier:
PDF, 1.13 MB
english, 2015